	US 12,018,335 B2
	Method for quantitatively detecting deletion of human CDKN2A gene copy, primers and use thereof
Dajun Deng, Beijing (CN); Yuan Tian, Beijing (CN); Jing Zhou, Beijing (CN); and Zhaojun Liu, Beijing (CN)
Assigned to BEIJING INSTITUTE FOR CANCER RESEARCH, Beijing (CN)
Appl. No. 17/611,311
Filed by Beijing Institute for Cancer Research, Beijing (CN)
PCT Filed May 16, 2019, PCT No. PCT/CN2019/087172 § 371(c)(1), (2) Date Nov. 15, 2021, PCT Pub. No. WO2020/228009, PCT Pub. Date Nov. 19, 2020.
Prior Publication US 2022/0275454 A1, Sep. 1, 2022
Int. Cl. C12Q 1/6886 (2018.01); C12Q 1/6851 (2018.01)

CPC C12Q 1/6886 (2013.01) [C12Q 1/6851 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/16 (2013.01)]

5 Claims

1. A set of an oligonucleotide primer pair and fluorescently labeled oligonucleotide probe, wherein the oligonucleotide primer pair comprises a first oligonucleotide comprising SEQ ID NO: 1 and a second oligonucleotide comprising SEQ ID NO:2, and the fluorescently labeled oligonucleotide probe comprises SEQ ID NO:3.